Our Firm
About Us
INTELLIGENT VALUE
For over 20 years, Orchard Capital Management has been providing investors with diversified, perceptive, and extensively researched strategies and solutions. As a research-driven firm, we focus on uncovering undervalued or underappreciated investments to drive both our asset management joint venture and intrinsic value offerings.
INTRINSIC VALUE
Proprietary Value Funds and
Separate Accounts
Orchard employs a consistent and disciplined approach with an emphasis on fundamental research to develop proprietary investment knowledge. We use this knowledge to drive our estimate of intrinsic value and invest at a significant discount to generate excess returns.
Our team approach was created to thoroughly examine and evaluate investment ideas and challenge market assumptions.
INVESTMENT PRINCIPLES
Long-term perspective
Rigorous research
Portfolio diversification
Accessibility
Partners
Mr. Harper has 20 years of investment management and advisory experience; he is the Chief Investment Officer of Orchard Capital Management and leads the family office that founded Orchard's small cap strategies in 2001.
Previously, Blake worked at the The Boston Consulting Group (BCG), where he advised large hedge funds, Fortune 1000 companies, and other financial institutions on strategy, corporate development and operations. Prior to BCG he was a senior research analyst in the investment management consulting division of Greenwich Associates. He began his career as an analyst at PaineWebber/UBS.
Blake received his MBA with honors from the University of Chicago and his BA from Colgate University where he concentrated on Economics and Political Science. He serves on several private company boards.
Blake Harper
Mr. Fairbank has over 20 years of investment management and private equity experience; he is the President of Orchard Capital Management.
In 2004, he co-founded and led the investment team at Orchard Ventures, a private equity fund. He is also the co-founder of several healthcare companies including Akebia (NASDAQ:AKBA) a spin-out from Procter & Gamble and Nymirum, a computational genetics firm where he serves as Executive Chairman.
Josh began his career at Frank Russell, one of the original major hedge fund of funds and fund advisors. He later founded an investment office at Raymond James where he managed investments for large family investors. He received his BA from Connecticut College and his MBA from the University of Chicago, where he serves as Investor-in-Residence and is an Adjunct Professor.
Joshua P. Fairbank
No client or potential client should assume that any information presented or made available on or through this website should be construed as personalized financial planning or investment advice. Personalized financial planning and investment advice can only be rendered after engagement of the firm for services, execution of the required documentation, and receipt of required disclosures. Please contact the firm for further information.
As general policy, the firm will not disclose personal financial information about any client to non-affiliated third parties except as necessary to establish and perform its investment advisory and financial planning services.
The firm will maintain physical, electronic, and procedural safeguards that comply with federal standards to guard each client’s personal financial information. Such safeguards include restricting the use of any information to those employees that need access to provide the firm’s services. Clients’ personal financial information will be maintained in the firm’s central files and will be secured after normal business hours.